Stem Cell Engraftment
Stem Cell Engraftment - Related Videos
04:36
Adenocarcinoma Engraftment: A Method to Implant Cancer Cells into the Murine Lungs
0 Views •
2023
This video describes a method to engraft lung adenocarcinoma cells in murine lungs by preconditioning the airways with fibrosis-inducing agent–bleomycin. This method significantly enhances orthotopic engraftment of lung cancer cells into murine...
22:06
Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells
0 Views •
Cited by 7 •
2007
This protocol details the derivation of transplantable hematopoietic stem cells from mouse embryonic stem cells (ESC) and their subsequent injection into lethally irradiated recipient mice. Briefly, ESC are differentiated as embryoid bodies, which are then infected with retroviral HoxB4 and co-cultured with OP9 stromal cells and hematopoietic cytokines.
09:02
Development, Expansion, and In vivo Monitoring of Human NK Cells from Human Embryonic Stem Cells (hESCs) and Induced Pluripotent Stem Cells (iPSCs)
0 Views •
Cited by 45 •
2013
This protocol describes the development, expansion, and in vivo imaging of NK cells derived from hESCs and iPSCs.
10:52
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
0 Views •
Cited by 1 •
2018
Mantle cell lymphoma (MCL) is a difficult to treat B cell disorder and it is equally difficult to establish a xenograft mouse model of primary MCL to study and develop therapeutics. Here, we describe the successful establishment of MCL xenografts in mice to help understand its underlying biology.
08:56
Fate Mapping of Human Embryonic Stem Cells by Teratoma Formation
0 Views •
Cited by 26 •
2010
Directed differentiation of hESCs into specific cells has generated much interest in regenerative medicine. We provide a concise, step-by-step protocol for determining the in vivo fate of selected hESCs that provides a valuable tool for characterizing tissue-specific reagents for cell-based therapy.
FAQs
The bone marrow niche provides a supportive microenvironment in which infused cells can home, adhere, and proliferate. Successful establishment therefore depends not only on delivery of the cells but also on their interaction with compatible tissue surroundings. These steps allow the transplanted population to expand and contribute to renewed blood-cell formation and immune function after transplantation.
Engraftment occurs after the recipient has received conditioning treatment, placing cell transplantation within a defined therapeutic sequence. The infused cells must then reach appropriate marrow niches and establish contact with supportive microenvironments before functional populations develop. This relationship makes conditioning, cell infusion, and subsequent recovery assessments interconnected parts of hematopoietic transplantation.
Cell dose, tissue compatibility, and immune responses are central variables investigated in stem cell engraftment. The number of transplanted cells may affect the available population, while compatibility and immune activity influence how well cells establish within recipient tissues. Researchers examine these factors together to identify conditions associated with more effective restoration of blood and immune functions.
Neutrophil and platelet recovery provide clinical measures for evaluating whether transplanted cells are producing functional blood-cell populations. They offer observable indicators of hematopoietic recovery after transplantation rather than relying only on the infusion event itself. Clinicians can use these measurements to assess progress, while researchers may relate recovery patterns to cell dose, compatibility, immune responses, or donor chimerism.
The process begins with conditioning treatment, followed by infusion of the transplanted cells. The cells then home to bone marrow niches, adhere to supportive microenvironments, and proliferate. Clinical assessment includes monitoring neutrophil and platelet recovery, while research evaluation may also examine cell dose, tissue compatibility, immune responses, and donor chimerism to understand the outcome.
Its most direct medical relevance is hematopoietic stem cell transplantation, where restored blood-cell formation and immune function are key outcomes. The same scientific focus also supports research in gene therapy, tissue repair, and personalized medicine. In each setting, investigators are concerned with how transplanted cells establish within recipient tissues and contribute to useful functional populations.
Donor chimerism is one of the features researchers study when evaluating stem cell engraftment and improving transplantation outcomes. Considered alongside cell dose, tissue compatibility, immune responses, and blood-cell recovery, it helps place engraftment within a broader assessment framework. This research context can guide efforts to optimize hematopoietic therapies and related regenerative or personalized approaches.